Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 3.070
+0.120 (4.07%)
At close: Jan 9, 2026
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.94 billion as of January 9, 2026. Its market cap has increased by 35.81% in one year.
Market Cap
3.94B
Enterprise Value
3.89B
Revenue
26.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.07
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.94B, an increase of 5,043.94%. That is a compound annual growth rate of 20.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.94B | 12.87% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.03B |
| Pro Medicus | 21.96B |
| Cochlear | 17.22B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 8.13B |
| Ansell | 4.77B |
| Telix Pharmaceuticals | 3.81B |
| 4DMedical | 2.47B |